Arterial blood gas testing plays a critical role in evaluating oxygenation, ventilation, and acid-base balance in patients requiring rapid clinical assessment. Growing respiratory disorders, metabolic conditions, and critical care requirements are increasing the need for reliable blood sampling solutions. Technological improvements in blood gas testing are further supporting faster, safer, and more standardized diagnostic workflows.

The Arterial Blood Gas Kits Market was valued at US$712.46 million in 2023 and is projected to reach US$1,298.03 million by 2031, registering a CAGR of 7.8% during 2024-2031. These kits are increasingly used across hospitals, clinics, diagnostic laboratories, emergency departments, and other healthcare settings to collect arterial blood samples for blood gas and electrolyte analysis. The increasing prevalence of respiratory and metabolic diseases, rising demand for point-of-care diagnostics, and advances in automated sampling technologies are expected to remain key contributors to growth.

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00012482

Rising Burden of Respiratory and Chronic Diseases

The increasing incidence of respiratory diseases is one of the primary factors driving demand for arterial blood gas kits. Conditions such as chronic obstructive pulmonary disease, asthma, pneumonia, acute respiratory distress syndrome, and respiratory failure often require assessment of oxygen and carbon dioxide levels in arterial blood. ABG testing also supports the management of metabolic disorders, diabetic ketoacidosis, renal conditions, heart failure, and other critical illnesses.

The growing geriatric population is another important growth factor. Older individuals are more susceptible to respiratory complications and chronic diseases that may require frequent monitoring. In emerging economies, expanding healthcare infrastructure and increasing awareness of respiratory conditions are creating additional opportunities for manufacturers. India, in particular, is expected to register a strong growth rate during the forecast period because of its large patient population, increasing healthcare expenditure, and expanding diagnostic capabilities.

Technological Advancements and Point-of-Care Diagnostics

The shift toward point-of-care testing is transforming the way arterial blood gas analysis is performed. Healthcare providers increasingly require rapid diagnostic information to make immediate treatment decisions, particularly in intensive care units, emergency departments, operating rooms, and neonatal care.

Modern arterial blood gas kits are being developed with features designed to improve sample collection accuracy, reduce handling complications, and support efficient testing. Pre-set plunger systems, safety mechanisms, specialized needles, and improved syringe designs can simplify blood collection while reducing the possibility of air contamination and sample-related errors.

Integration of point-of-care analyzers with digital healthcare systems and electronic medical records is also supporting more efficient clinical workflows. Automated data transfer can help healthcare professionals access test results quickly and incorporate them into broader patient management strategies. These developments are expected to encourage adoption across both established and emerging healthcare systems.

Segmental Analysis and Key Growth Areas

By syringe type, Luer Lock Syringes accounted for the largest share in 2023, representing 58.5% of the segment. Their secure connection design makes them suitable for arterial blood collection procedures where reliable needle attachment is important.

Based on usage, the Pre-Set Plunger Mode segment held the largest share, accounting for 75.1% in 2023. Pre-set systems offer convenience and standardized sample collection, making them particularly valuable in high-volume clinical environments.

By application, In Vitro Diagnostics is expected to register significant growth, with a projected CAGR of 8.2%. Within this segment, pH blood gas represented the largest share at 58.7% in 2023. The 23G to 25G needle gauge segment is expected to grow at an 8.3% CAGR, while the 3 ml syringe volume segment led with a 47.3% share in 2023. Hospitals and clinics are expected to remain a major end-user segment, supported by increasing critical care and emergency diagnostic requirements.

Regional Landscape and Competitive Environment

North America dominated the global landscape with a 42.4% share in 2023, supported by advanced healthcare infrastructure, high adoption of point-of-care testing, and a substantial burden of respiratory and chronic diseases. The US is projected to grow at a CAGR of 7.5% during the forecast period. Demand is supported by the widespread use of ABG analysis for respiratory failure, ARDS, asthma, diabetic ketoacidosis, renal disorders, and heart failure.

Asia Pacific is anticipated to demonstrate strong expansion, registering a projected CAGR of 8.6%. Rising healthcare investments, growing awareness of advanced diagnostics, increasing patient populations, and improving access to point-of-care technologies are contributing to regional opportunities.

Key players operating in the industry include:

• BD
• Radiometer Medical ApS
• Siemens Healthineers AG
• Vyaire Medical Inc
• ICU Medical Inc
• SARSTEDT AG & Co KG
• Opti Medical Systems
• Lepu Medical Technology Beijing Co Ltd
• Levram Lifesciences Pvt. Ltd.
• SunMed Group Holdings LLC (AirLife)

These companies are focusing on product innovation, safety improvements, automation, and broader distribution networks to strengthen their competitive positions.

Future Outlook

The Arterial Blood Gas Kits Market is positioned for sustained growth as healthcare providers prioritize rapid diagnostics, critical care efficiency, and patient-specific treatment decisions. The industry is expected to benefit from the increasing prevalence of respiratory and metabolic disorders, expansion of point-of-care testing, and development of safer and more automated blood collection systems.

Related Report:

1) Biologics Market Growth, Trends, and Analysis by 2031

2) Antibody Production Market Share, Growth & Forecast by 2034

3) Contract Research Organization Market Analysis and Forecast by Size

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish